Merck Disagrees With Vioxx Analysis Pharmaceutical company Merck  amp; Co.  quot;strongly quot; disagreed Thursday with the conclusions of a Food and Drug Administration-funded study that said use of the company #39;s arthritis pain reliever Vioxx increased the risk of heart attack.